Insys Therapeutics, Inc
Recent News About Insys Therapeutics, Inc View More
-
'Absolute panic' as cities, counties face deadline on opioid 'negotiation class'
CLEVELAND (Legal Newsline) - Cities and counties are worried and confused as they face a November deadline to join or opt out of an unprecedented “negotiation class” that could determine how much money they get from opioid litigation, a lawyer who represents Texas municipalities said. -
A dissident emerges in Pennsylvania's opioid litigation: Lehigh Co. claims its case has been highjacked
The fight for control of Pennsylvania’s opioid litigation is not over, as Lehigh County is not happy that its case has been grouped in with more than 30 others and that lawyers it previously rejected have been tasked with overseeing the proceedings. -
North Carolina AG files complaint against Insys Therapeutics for alleged fentanyl kickback scheme
RALEIGH, N.C. (Legal Newsline) — North Carolina Attorney General Josh Stein announced May 21 that he filed a complaint against Insys Therapeutics Inc. for allegations of deceptive marketing and sales practices in violation of the Fair Claims Act.